Fiorella David, Woo Henry H, Albuquerque Felipe C, Nelson Peter K
Department of Neuroradiology and Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Neurosurgery. 2008 May;62(5):1115-20; discussion 1120-1. doi: 10.1227/01.neu.0000325873.44881.6e.
The Pipeline embolization device (PED; Chestnut Medical, Menlo Park, CA) is a new endovascular construct designed to exclude aneurysms from the parent cerebrovasculature. We report the results of the first two human implantations of this device in North America.
Two patients presenting with large, symptomatic, circumferential, fusiform intracranial vertebral artery aneurysms were treated with the PED. In both cases, more traditional open microneurosurgical and neuroendovascular treatment strategies had either failed or were associated with unacceptably high risk.
Three PEDs were placed across the aneurysms in each of the patients to achieve reconstruction of a new parent vessel through the center of a circumferential aneurysm. In the first patient, who had previously been treated with stent-supported coil embolization, the PED construct alone was sufficient to achieve parent vessel reconstruction and exclusion of the recurrent aneurysm. In the second patient, a microcatheter was jailed within the saccular portion of the aneurysm and the parent vessel was reconstructed with three telescoped PEDs. Although the PED construct dramatically reduced flow into the aneurysm, the lesion remained patent. Coiling of the saccular portion of the aneurysm was subsequently performed via the jailed microcatheter. Follow-up angiography performed 72 hours after the procedure demonstrated occlusion of the aneurysm with cylindrical reconstruction of the affected vascular segment. Neither patient has experienced any complication in the periprocedural period (30 d) or during subsequent long-term (>1 year) follow-up.
The PED represents an important advance in the endovascular therapy of cerebral aneurysms, targeting primary parent vessel reconstruction rather than endosaccular occlusion as a means by which to achieve exclusion of the aneurysm and definitive anatomic reconstruction of the parent artery.
管道栓塞装置(PED;栗树医疗公司,加利福尼亚州门洛帕克)是一种新型血管内器械,旨在将动脉瘤与母脑血管系统隔离开。我们报告该装置在北美的前两例人体植入结果。
两名患有大型、有症状、环形、梭形颅内椎动脉动脉瘤的患者接受了PED治疗。在这两例病例中,更传统的开放式显微神经外科和神经血管内治疗策略均告失败或伴有不可接受的高风险。
在每位患者的动脉瘤上放置三个PED,以实现通过环形动脉瘤中心重建一条新的母血管。在第一例先前接受过支架辅助弹簧圈栓塞治疗的患者中,单独使用PED结构就足以实现母血管重建并排除复发性动脉瘤。在第二例患者中,一根微导管被困在动脉瘤的囊状部分内,并用三个套叠式PED重建母血管。尽管PED结构显著减少了流入动脉瘤的血流,但病变仍保持通畅。随后通过被困的微导管对动脉瘤的囊状部分进行弹簧圈栓塞。术后72小时进行的随访血管造影显示动脉瘤闭塞,受累血管段呈圆柱形重建。两名患者在围手术期(30天)或随后的长期(>1年)随访中均未出现任何并发症。
PED代表了脑动脉瘤血管内治疗的一项重要进展,其目标是进行原发性母血管重建,而非囊内闭塞,以此作为实现动脉瘤隔离和母动脉确定性解剖重建的手段。